Tag: Hummingbird Bioscience

Hummingbird Bioscience raises $125 Mn Series C funding led by Novo Holdings

Novo Holdings announced that it has led the oversubscribed US$125 million Series C financing in Hummingbird Bioscience (Hummingbird), an innovative clinical-stage biotech company focused on developing precision therapies against difficult-to-drug targets to improve treatment outcomes.  This is one of the first investments in a privately-held Asian biotech company by Novo Holdings. Novo Holdings recently established…